Synapse-specific Opioid Modulation of Thalamo-cortico-striatal Circuits

  1. William T Birdsong  Is a corresponding author
  2. Bart C Jongbloets
  3. Kim A Engeln
  4. Dong Wang
  5. Gregory Scherrer
  6. Tianyi Mao  Is a corresponding author
  1. Oregon Health and Science University, United States
  2. Stanford University, United States

Abstract

The medial thalamus (MThal), anterior cingulate cortex (ACC) and striatum play important roles in affective-motivational pain processing and reward learning. Opioids affect both pain and reward through uncharacterized modulation of this circuitry. This study examined opioid actions on glutamate transmission between these brain regions in mouse. Mu-opioid receptor (MOR) agonists potently inhibited MThal inputs without affecting ACC inputs to individual striatal medium spiny neurons (MSNs). MOR activation also inhibited MThal inputs to the pyramidal neurons in the ACC. In contrast, delta-opioid receptor (DOR) agonists disinhibited ACC pyramidal neuron responses to MThal inputs by suppressing local feed-forward GABA signaling from parvalbumin-positive interneurons. As a result, DOR activation in the ACC facilitated poly-synaptic (thalamo-cortico-striatal) excitation of MSNs by MThal inputs. These results suggest that opioid effects on pain and reward may be shaped by the relative selectivity of opioid drugs to the specific circuit components.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files. All code and data are deposited in https://gitlab.com/maolab/opi_syn_circuit. ecfa1f13.

Article and author information

Author details

  1. William T Birdsong

    Vollum Institute, Oregon Health and Science University, Portland, United States
    For correspondence
    wtbird@med.umich.edu
    Competing interests
    The authors declare that no competing interests exist.
  2. Bart C Jongbloets

    Vollum Institute, Oregon Health and Science University, Portland, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Kim A Engeln

    Vollum Institute, Oregon Health and Science University, Portland, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Dong Wang

    Department of Anesthesiology, Perioperative and Pain Medicine, Department of Molecular and Cellular Physiology, Department of Neurosurgery, Stanford University, Palo Alto, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Gregory Scherrer

    Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Palo Alto, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Tianyi Mao

    Vollum Institute, Oregon Health and Science University, Portland, United States
    For correspondence
    mao@ohsu.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3532-8319

Funding

National Institute of Neurological Disorders and Stroke (R01NS081071)

  • Tianyi Mao

New York Stem Cell Foundation

  • Gregory Scherrer

National Institute on Drug Abuse (R01DA042779)

  • William T Birdsong

National Institute on Drug Abuse (R01DA044481)

  • Gregory Scherrer

National Institute on Drug Abuse (R01NS106301)

  • Gregory Scherrer

National Institute of Neurological Disorders and Stroke (R01NS104944)

  • Tianyi Mao

National Institute of Neurological Disorders and Stroke (U01NS094247)

  • Tianyi Mao

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All procedures were approved by Oregon Health & Science University Institutional Animal Care and Use Committee (IACUC) and all experiments were performed strictly according the approved protocols. IACUC protocol IP00000955, and Institutional Biosafety Committee protocol IBC-10-40.

Copyright

© 2019, Birdsong et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 711
    downloads
  • 50
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. William T Birdsong
  2. Bart C Jongbloets
  3. Kim A Engeln
  4. Dong Wang
  5. Gregory Scherrer
  6. Tianyi Mao
(2019)
Synapse-specific Opioid Modulation of Thalamo-cortico-striatal Circuits
eLife 8:e45146.
https://doi.org/10.7554/eLife.45146

Share this article

https://doi.org/10.7554/eLife.45146

Further reading

    1. Neuroscience
    Donald Iain MacDonald, Monessha Jayabalan ... Alexander Theodore Chesler
    Research Article

    The neuropeptides Substance P and CGRPα have long been thought important for pain sensation. Both peptides and their receptors are expressed at high levels in pain-responsive neurons from the periphery to the brain making them attractive therapeutic targets. However, drugs targeting these pathways individually did not relieve pain in clinical trials. Since Substance P and CGRPα are extensively co-expressed, we hypothesized that their simultaneous inhibition would be required for effective analgesia. We therefore generated Tac1 and Calca double knockout (DKO) mice and assessed their behavior using a wide range of pain-relevant assays. As expected, Substance P and CGRPα peptides were undetectable throughout the nervous system of DKO mice. To our surprise, these animals displayed largely intact responses to mechanical, thermal, chemical, and visceral pain stimuli, as well as itch. Moreover, chronic inflammatory pain and neurogenic inflammation were unaffected by loss of the two peptides. Finally, neuropathic pain evoked by nerve injury or chemotherapy treatment was also preserved in peptide-deficient mice. Thus, our results demonstrate that even in combination, Substance P and CGRPα are not required for the transmission of acute and chronic pain.

    1. Neuroscience
    Sean McCracken, Liam McCoy ... Josh L Morgan
    Research Article

    In albino mice and EphB1 knockout mice, mistargeted retinal ganglion cell axons form dense islands of axon terminals in the dorsal lateral geniculate nuclei (dLGN). The formation of these islands of retinal input depends on developmental patterns of spontaneous retinal activity. We reconstructed the microcircuitry of the activity-dependent islands and found that the boundaries of the island represent a remarkably strong segregation within retinogeniculate connectivity. We conclude that when sets of retinal input are established in the wrong part of the dLGN, the developing circuitry responds by forming a synaptically isolated subcircuit within the otherwise fully connected network. The fact that there is a developmental starting condition that can induce a synaptically segregated microcircuit has important implications for our understanding of the organization of visual circuits and our understanding of the implementation of activity-dependent development.